ISRCTN86750102 : CRASH2 Trial, a large randomised placebo-controlled trial among trauma patients with significant haemorrhage of the effects of an antifibrinolytic treatment on death and transfusion requirement
- Overall trial status
- Completed
- Recruitment status
- No longer recruiting
Published
Cameroon
Signs and Symptoms